Lexeo Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $135.9M |
| FY2022 | $25.0M | $97.1M | $77.3M |
| FY2023 | $26.3M | $139.8M | $121.5M |
| FY2024 | $30.1M | $146.9M | $35.0M |
| FY2025 | $22.0M | $268.7M | $63.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $135.9M |
| FY2022 | $25.0M | $97.1M | $77.3M |
| FY2023 | $26.3M | $139.8M | $121.5M |
| FY2024 | $30.1M | $146.9M | $35.0M |
| FY2025 | $22.0M | $268.7M | $63.0M |